Built by People Who Knew
What Getting It Wrong Costs

ParadigmForge is a Canadian regulatory technology company building AI platforms for the sectors where a wrong answer has real consequences: environmental assessment, medical devices, natural health products, food safety, chemical compliance, trade, and compliance auditing.

We're not a general-purpose AI company that moved into regulatory. We're a regulatory company that built the AI architecture it needed — because nothing on the market was built to the standard these domains actually require.

A single federal Environmental Assessment can run 500 pages. Review teams must cross-reference every cited species against SARA schedules, every proposed mitigation against established thresholds, every consultation record against duty-to-consult obligations. Manually. Every time.

The same pattern repeats across medical device submissions, NHP licence applications, REACH dossiers, and trade compliance reviews. Enormous expert capacity consumed by work that no prior technology could do reliably enough to trust.

The first generation of regulatory AI tools made a consistent mistake: take a general-purpose language model, feed it regulatory documents, call it a compliance platform. The result was systems that sounded authoritative and failed in ways that were hard to detect.

We concluded the problem wasn't the model — it was the architecture. A reliable regulatory AI needs a verified record it cannot fabricate around, a structural understanding of how regulations relate to each other, and a mechanism that challenges its own findings before they reach you.

Every ParadigmForge platform includes an independent adversarial validator whose mandate is to reject findings — not confirm them. It doesn't see the generator's reasoning or its confidence score. It receives only the finding and the evidence chain, and starts from scratch.

Findings that don't survive that challenge are discarded before they reach you. What you see has already been independently stress-tested — and that's what makes a confidence rating on a critical flag mean something real.

Every ParadigmForge deployment runs on Canadian infrastructure. Your documents, your review decisions, and your institutional knowledge stay in Canada — not by policy statement, but by architecture. No query transits a US or offshore server.

This wasn't a market positioning decision. It was the right decision for the customers we built this for: federal and provincial government agencies, regulated manufacturers, and regulatory affairs professionals who cannot send their most sensitive work across a border.

Boreal Caribou is Schedule 1 Threatened under SARA. Its presence in a project footprint triggers mandatory duties under sections 32, 58, 73, and 79. Failure to address those obligations is grounds for judicial review.

EIA Pro surfaces this gap in minutes: resolves the species to its SARA listing, retrieves applicable obligations, checks the EIA record, generates a finding with full legislative provenance, and sends it through adversarial validation before it reaches the reviewer. Experienced reviewers catch this on their best days. EIA Pro finds it every time.

Rule 22 requires clinical investigations for Class IIb implantables unless equivalence can be demonstrated with clinical data — not just technical similarity. MedDevicePro answers it in seconds: specific MDR article, evidence standard, and timeline data from thousands of real approval records.

EU MDR transition caught hundreds of manufacturers unprepared. FDA QMSR is reshaping 21 CFR 820 right now. The manufacturers who navigate successfully are the ones who know what's changing before it changes.

The regulated world runs on accurate, defensible, source-traceable guidance. The cost of getting it wrong — project delays, failed submissions, missed obligations, legal exposure — runs to billions annually across the Canadian economy. That cost is not inevitable. It is the result of inadequate tools.

Seven platforms. One architecture. One standard: every answer traceable, every critical finding independently validated, all of it on Canadian soil. Merrickville, Ontario.